{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:48:19Z","timestamp":1777924099527,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.7759\/cureus.108113","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:11:47Z","timestamp":1777669907000},"source":"Crossref","is-referenced-by-count":0,"title":["Quadruple Non-Insulin Therapy for Advanced Type 2 Diabetes Mellitus With Cognitive Impairment: A Case Report"],"prefix":"10.7759","author":[{"given":"Stjepan","family":"Skudar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-SINT","article-title":"Introduction and methodology: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. Introduction and methodology: standards of care in diabetes-2025. Diabetes Care. 2025, 48:S1-5. 10.2337\/dc25-SINT","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73138","article-title":"Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK Biobank and meta-analyses","volume":"11","author":"Antal B","year":"2022","unstructured":"Antal B, McMahon LP, Sultan SF, et al.. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK Biobank and meta-analyses. Elife. 2022, 11:73138. 10.7554\/eLife.73138","journal-title":"Elife"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiomech.2022.105759","article-title":"Type 2 diabetes mellitus and obesity: the synergistic effects on human locomotor function","volume":"100","author":"Tramonti C","year":"2022","unstructured":"Tramonti C, Iacopi E, Cafalli M, Riitano N, Piaggesi A, Chisari C. Type 2 diabetes mellitus and obesity: the synergistic effects on human locomotor function. Clin Biomech (Bristol). 2022, 100:105759. 10.1016\/j.clinbiomech.2022.105759","journal-title":"Clin Biomech (Bristol)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain M","year":"2019","unstructured":"Husain M, Birkenfeld AL, Donsmark M, et al.. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2019, 381:841-51. 10.1056\/NEJMoa1901118","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine ZS","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al.. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005, 53:695-9. 10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173037","article-title":"The protective role of DPP4 inhibitors in atherosclerosis","volume":"875","author":"Liu H","year":"2020","unstructured":"Liu H, Guo L, Xing J, et al.. The protective role of DPP4 inhibitors in atherosclerosis. Eur J Pharmacol. 2020, 875:173037. 10.1016\/j.ejphar.2020.173037","journal-title":"Eur J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i48.5205","article-title":"GLP-1, GIP\/GLP-1, and GCGR\/GLP-1 receptor agonists: novel therapeutic agents for metabolic dysfunction-associated steatohepatitis","volume":"30","author":"Singh A","year":"2024","unstructured":"Singh A, Sohal A, Batta A. GLP-1, GIP\/GLP-1, and GCGR\/GLP-1 receptor agonists: novel therapeutic agents for metabolic dysfunction-associated steatohepatitis. World J Gastroenterol. 2024, 30:5205-11. 10.3748\/wjg.v30.i48.5205","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso SP","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al.. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016, 375:1834-44. 10.1056\/NEJMoa1607141","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding JP","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, et al.. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021, 384:989-1002. 10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies MJ","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, et al.. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022, 45:2753-86. 10.2337\/dci22-0034","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/490094-quadruple-non-insulin-therapy-for-advanced-type-2-diabetes-mellitus-with-cognitive-impairment-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:11:48Z","timestamp":1777669908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/490094-quadruple-non-insulin-therapy-for-advanced-type-2-diabetes-mellitus-with-cognitive-impairment-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.108113","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}